Skip to main content
Loading

OYE Therapeutics, Inc.

October 17, 2023
Franciscan D
CNS/Neurological
OYE is a clinical stage pharmaceutical company focused on a late stage, low risk 505(b)2 opportunity that has already achieved market adoption and uptake in the hospital market.
Speakers
Brett Dines - OYE Therapeutics, Inc.